Miscellaneous Topics l Chemoprevention of Breast Cancer l Nutrition & Breast Cancer Prevention
Genetics, Hereditary Breast Cancer l Hormone Replacement & Breast Risk
Lifestyle & Breast Cancer Prevention l Prophylactic Mastectomies
Pathogenesis of Breast Cancer

Miscellaneous topics

Effects of soy foods on ovarian function in premenopausal women.
Wu, A. H.; Stanczyk, F. Z.; Hendrich, S.; Murphy, P. A.; Zhang, C.; Wan, P., and Pike, M. C. (Reprint available from: Wu AH Univ So Calif, Sch Med, Kenneth Norris Jr Comprehens Canc Ctr, Dept Prevent Med 1441 Eastlake Ave,MS 44,POB 33800 Los Angeles, CA 90089 USA).. British Journal of Cancer. 82(11):1879-1886, 2000 Jun.

HER-2/neu amplification in benign breast disease and the risk of subsequent breast cancer.
Stark, A.; Hulka, B. S.; Joens, S.; Novotny, D.; Thor, A. D.; Wold, L. E.; Schell, M. J.; Melton, L. J.; Liu, E. T., and Conway, K. Journal of Clinical Oncology. 18(2):267-274, 2000 Jan.

Hormonal contraception and chemoprevention of female cancers [Review].
Pike, M. C. and Spicer,D. V.. Endocrine-Related Cancer. 7(2):73-83, 2000 Jun. Molecular epidemiology:

On the path to prevention? [Review].
Perera, F. P. (Reprint available from: Perera FP Columbia Univ, Joseph L Mailman Sch Publ Hlth, Div Environm Hlth Sci New York, NY 10032 USA). Journal of the National Cancer Institute. 92(8):602-612, 2000 Apr 19

Molecular epidemiology: On the path to prevention? [Review].
Perera, F. P. (Reprint available from: Perera FP Columbia Univ, Joseph L Mailman Sch Publ Hlth, Div Environm Hlth Sci New York, NY 10032 USA). Journal of the National Cancer Institute. 92(8):602-612, 2000 Apr 19

Breast carcinoma etiology - Current knowledge and new insights into the effects of reproductive and hormonal risk factors in black and white populations.
Pathak, D. R.; Osuch, J. R., and He, J. P. Cancer. 88(5 Suppl S):1230-1238, 2000 Mar 1.

Urinary androgens and breast cancer risk: results from a long-term prospective study based in Guernsey
Wang, D. Y.; Allen, D. S.; De Stavola, B. L.; Fentiman, I. S.; Brussen, J.; Bulbrook, R. D.; Thomas, B. S.; Hayward, J. L., and Reed, M. J. (Reprint available from: Fentiman IS Univ London London Sch Hyg & Trop Med, Dept Epidemiol & Publ Hlth Keppel St London WC1E 7HT England. British Journal of Cancer. 82(9):1577-1584, 2000 May.

Canadian National Breast Screening Study-2: 13-year results of a randomized trial in women aged 50-59 years
Miller, A. B.; To, T.; Baines, C. J., and Wall, C. (Reprint available from: Miller AB Deutsch Krebsforschungszentrum, Div Clin Epidemiol Neuenheimer Feld 280 D-69120 Heidelberg Germany).. Journal of the National Cancer Institute. 92(18):1490-1499, 2000 Sep 20.

Declining cancer rates in the 1990s
McKean-Cowdin, R.; Feigelson, H. S.; Ross, R. K.; Pike, M. C., and Henderson, B. E.. Journal of Clinical Oncology. 18(11):2258-2268, 2000 Jun.

Genetic and hormonal risk factors in breast cancer [Review].
Martin, A. M. and Weber, B. L. (Reprint available from: Weber BL Univ Penn, Div Hematol & Oncol, Dept Med Rm 316A,BRB2-3,421 Curie Blvd Philadelphia, PA 19104 USA). Journal of the National Cancer Institute. 92(14):1126-1135, 2000 Jul 19.

Associations between community income and cancer incidence in Canada and the United States
Mackillop, W. J.; Zhang-Salomons, J.; Boyd, C. J., and Groome, P. A.. Cancer. 89(4):901-912, 2000 Aug 15.

History of breast-feeding in relation to breast cancer risk: a review of the epidemiologic literature [Review].
Lipworth, L.; Bailey, L. R., and Tricholpoulos, D. (Reprint available from: Lipworth L Int Epidemiol Inst 1455Res Blvd,Suite 550 Rockville, MD 20850 USA). Journal of the National Cancer Institute. 92(4):302-312, 2000 Feb 16.

Environmental and heritable factors in the causation of cancer - Analyses of cohorts of twins from Sweden, Denmark, and Finland
Lichtenstein, P.; Holm, N. V.; Verkasalo, P. K.; Iliadou, A.; Kaprio, J.; Koskenvuo, M.; Pukkala, E.; Skytthe, A., and Hemminki, K.. New England Journal of Medicine. 343(2):78-85, 2000 Jul 13.

Does antibacterial treatment for urinary tract infection contribute to the risk of breast cancer?
Knekt, P.; Adlercreutz, H.; Rissanen, H.; Aromaa, A.; Teppo, L., and Heliovaara, M. (Reprint available from: Knekt P Natl Publ Hlth Inst Mannerheimintie 166 SF-00300 Helsinki Finland). British Journal of Cancer. 82(5):1107-1110, 2000 Mar.

Migration patterns and breast carcinoma.
Kaur, J. S. Cancer. 88(5 Suppl S):1203-1206, 2000 Mar 1.

International Union Against Cancer. Classification of isolated tumor cells and micrometastasis.
Hermanek, P.; Hutter, R. V. P.; Sobin, L. H., and Wittekind, C. Cancer. 86(12):2668-2673, 1999 Dec 15.

Risk of breast cancer with oral contraceptive use in women with a family history of breast cancer.
Grabrick, D. M.; Hartmann, L. C.; Cerhan, J. R.; Vierkant, R. A.; Therneau, T. M.; Vachon, C. M.; Olson, J. E.; Couch, F. J.; Anderson, K. E.; Pankratz, V. S., and Sellers, T. A.. Jama: Journal of the American Medical Association. 284(14):1791-1798, 2000 Oct 11.

Short-term breast cancer prediction by random periareolar fine-needle aspiration
cytology and the Gail risk model [Review].
Fabian, C. J.; Kimler, B. F.; Zalles, C. M.; Klemp, J. R.; Kamel, S.; Zeiger, S., and Mayo, M. S. (Reprint available from: Fabian CJ Univ Kansas, Med Ctr, Dept Internal Med, Div Clin Oncol 3901 Rainbow Blvd Kansas City, KS 66160 USA). Journal of the National Cancer Institute. 92(15):1217-1227, 2000 Aug 2.

Twinship and risk of postmenopausal breast cancer.
Cerhan, J. R.; Kushi, L. H.; Olson, J. E.; Rich, S. S.; Zheng, W.; Folsom, A. R., and Sellers, T. A. (Reprint available from: Cerhan JR Mayo Clin & Mayo Fdn, Dept Hlth Sci Res 200 1st St SW Rochester, MN 55905 USA).. Journal of the National Cancer Institute. 92(3):261-265, 2000 Feb 2.

Annual cancer incidence rates for hispanics in the United States - Surveillance, epidemiology, and end results, 1992-1996
Canto, M. T. and Chu, K. C.. Cancer. 88(11):2642-2652, 2000 Jun 1.

Tubal ligation and risk of breast cancer Brinton, L. A.; Gammon, M. D.; Coates, R. J., and Hoover, R. N.
(Reprint available from: Brinton LA NCI, Environm Epidemiol Branch Execut Plaza S,Rm 7068,6120 Execute Blvd,MSC 7234 Bethesda, MD 20892 USA).. British Journal of Cancer. 82(9):1600-1604, 2000 May.

Breast density and cancer risk: What is the relationship?
White, J. Journal of the National Cancer Institute. 92(6):443, 2000 Mar 15. No abstract

Aberrant retinoid signaling and breast cancer: the view from outside the nucleus. Spinella, M. J. and Dmitrovsky, E. (Reprint available from: Dmitrovsky E Dartmouth Med Sch, Dept Pharmacol & Toxicol 7650 Remsen Hanover, NH 03755 USA). Aberrant retinoid signaling and breast cancer: the view from outside the nucleus. Journal of the National Cancer Institute. 92(6):438-440, 2000 Mar 15. No abstract

How toxic is DDT?
Smith, A. G. (Reprint available from: Smith AG Univ Leicester, MRC,Toxicol Unit Leicester LE1 9HN Leics England). Lancet. 356(9226):267-268, 2000 Jul 22. No abstract

History of breast-feeding in relation to breast cancer risk: a review of the epidemiologic literature
Rosenblatt, K. A.; Gao, D. L.; Ray, R. M., and Thomas, D. B. (Reprint available from: Rosenblatt KA Univ Illinois, Dept Community Hlth 120 Huff Hall, 1206 S 4th St Champaign, IL 61820 USA).. Journal of the National Cancer Institute. 92(11):942, 2000 Jun 7. No abstract

Silicone breast implants not linked to breast cancer risk.
Nelson, N. J.. Journal of the National Cancer Institute. 92(21):1714-1715, 2000 Nov 1. No abstract

Alcohol and breast cancer mortality in a cohort study.
Jain, M. G.; Ferrence, R. G.; Rehm, J. T.; Bondy, S. J.; Rohan, T. E.; Ashley, M. J.; Cohen, J. E., and Miller, A. B. (Reprint available from: Jain MG Univ Toronto, Dept Publ Hlth Sci McMurrich Bldg, 3rd Floor,12 Queens Pk Crescent W Toronto ON M5S 1A8 Canada).. Breast Cancer Research & Treatment. 64(2):201-209, 2000 Nov.

Refining breast cancer risk assessment with molecular markers: the next step?
Ellis, M. J. and Hayes, D. F. (Reprint available from: Hayes DF Georgetown Univ, Med Ctr, Lombardi Canc Ctr, Breast Canc Program 3970 Reservoir Rd NW Washington, DC 20007 USA). Journal of the National Cancer Institute. 91(24):2067-2068, 1999 Dec 15. No abstract

Primary care: Reducing the risk of breast cancer [Review].
Chlebowski, R. T. (Reprint available from: Chlebowski RT Univ Calif Los Angeles, Los Angeles Cty Harbor Med Ctr, Res & Educ Inst 1124 W Carson St,Bldg J-3 Torrance, CA 90502 USA). New England Journal of Medicine. 343(3):191-198, 2000 Jul 20. No abstract

Organochlorine pesticide content of breast adipose tissue from women with breast cancer and control subjects
Bagga, D.; Anders, K. H.; Wang, H. J.; Roberts, E., and Glaspy, J. A. (Reprint available from: Glaspy JA 200 UCLA Med Plaza,Suite 120-64 Los Angeles, CA 90095 USA).. Journal of the National Cancer Institute. 92(9):750-753, 2000 May 3. No abstract

Assessing the risk of breast cancer. [Review
Armstrong, K.; Eisen, A., and Weber, B. (Reprint available from: Armstrong K 1233 Blockley Hall,423 Guardian Dr Philadelphia, PA 19104 USA).]. New England Journal of Medicine. 342(8):564-571, 2000 Feb 24. No abstract

More about: Effect of hormone replacement therapy on breast cancer risk: Estrogen versus estrogen plus progestin.
Magnusson, C.; Persson, I., and Adami, H. O. (Reprint available from: Magnusson C Karolinska Inst, Dept Med Epidemiol POB 281 S-17177 Stockholm Sweden).. Journal of the National Cancer Institute. 92(14):1183-1184, 2000 Jul 19. No abstract

Top of Page

Chemoprevention of breast cancer

Tamoxifen should be cost-effective in reducing breast cancer risk in high-risk women
Smith, T. J. and Hillner, B. E.. Journal of Clinical Oncology. 18(2):284-286, 2000 Jan.

Estimation of tamoxifen's efficacy for preventing the formation and growth of breast tumors.
Radmacher, M.D., Simon, R. -- (Reprint available from: Radmacher MD NIH 7550 Wisconsin Ave,MS 9015 Bethesda, MD 20892 USA).. Journal of the National Cancer Institute. 92(1):48-53, 2000 Jan 5.

Tamoxifen and risk of contralateral breast cancer in BRCA1 and BRCA2 mutation carriers: a case-control study
Narod, S. A.; Brunet, J. S.; Ghadirian, P.; Robson, M.; Heimdal, K.; Neuhausen, S. L.; Stoppa-Lyonnet, D.; Lerman, C.; Pasini, B.; de los Rios, P.; Weber, B., and Lynch, H.. Lancet. 356(9245):1876-1881, 2000 Dec 2.

Chemoprevention options for BRCA1 and BRCA2 mutation carriers.
Eeles, R. A. and Powles, T. J. Journal of Clinical Oncology. 18(21 Suppl S):93S-99S, 2000 Nov 1.

Chemoprevention of breast cancer [Review].
Brown, P. H. and Lippman, S. M. (Reprint available from: Lippman SM Univ Texas, MD Anderson Canc Ctr, Dept Clin Canc Prevent 1515 Holcombe Blvd,Box 236 Houston, TX 77030 USA). Breast Cancer Research & Treatment. 62(1):1-17, 2000 Jul.

Hormonal approaches to the chemoprevention of endocrine-dependent tumors.
Manni, A.. Endocrine-Related Cancer. 6(4):483-485, 1999 Dec.

Pilot trial of the safety, tolerability, and retinoid levels of N-(4-hydroxyphenyl) retinamide in combination with tamoxifen in patients at high risk for developing invasive breast cancer.
Conley, B.; O'Shaughnessy, J.; Prindiville, S.; Lawrence, J.; Chow, C.; Jones, E.; Merino, M. J.; Kaiser-Kupfer, M. I.; Caruso, R. C.; Podger, M.; Goldspiel, B.; Venzon, D.; Danforth, D.; Wu, S. L.; Noone, M.; Goldstein, J.; Cowan, K. H., and Zujewski, J.. Journal of Clinical Oncology. 18(2):275-283, 2000 Jan.

Vitamin A analogue for breast cancer prevention: a grade of F or incomplete? Response
Piantadosi, S. (Reprint available from: Piantadosi S Johns Hopkins Univ, Sch Med, Johns Hopkins Oncol Ctr 550 N Broadway,Suite 1103 Baltimore, MD 21205 USA).. Journal of the National Cancer Institute. 92(3):274-275, 2000 Feb 2. No abstract

Tamoxifen for the prevention of breast cancer in the high-risk woman.
Morrow, M. and Jordan, V. C. (Reprint available from: Morrow M 676 N St Clair St,13th Floor, Room 13-104 Chicago, IL 60611 USA).. Annals of Surgical Oncology. 7(1):67-71, 2000 Jan-Feb. No abstract

Top of Page

Nutrition and breast cancer prevention

Dietary fat, fat subtypes, and breast cancer in postmenopausal women: A prospective cohort study.
Velie, E.; Kulldorff, M.; Schairer, C.; Block, G.; Albanes, D., and Schatzkin, A. (Reprint available from: Velie E NIH 6120 Execut Blvd,MSC 7232,EPS,Rm 7026 Bethesda, MD 20892 USA). Journal of the National Cancer Institute. 92(10):833-839, 2000 May 17.

High risk mammographic parenchymal patterns and diet: a case-control study.
Sala, E.; Warren, R.; Duffy, S.; Welch, A.; Luben, R., and Day, N. (Reprint available from: Sala E Strangeways Res Lab, Dept Publ Hlth & Primary Care Worts Causeway Cambridge CB1 8RN England).. British Journal of Cancer. 83(1):121-126, 2000 Jul.

Associations between energy balance and body mass index and risk of breast carcinoma in women from diverse racial and ethnic backgrounds in the US.
McTiernan, A. (Reprint available from: McTiernan A Fred Hutchinson Canc Res Ctr, Canc Prevent Res Program MP-1002,1100 Fairview Ave N Seattle, WA 98109 USA). Cancer. 88(5 Suppl S):1248-1255, 2000 Mar 1.

The association of increased weight, body mass index, and tissue density with the risk of breast carcinoma in Vermont.
Lam, P. B.; Vacek, P. M.; Geller, B. M., and Muss, H. B.. Cancer. 89(2):369-375, 2000 Jul 15.

Dietary fat intake and endogenous sex steroid hormone levels in postmenopausal women.
Holmes, M. D.; Spiegelman, D.; Willett, W. C.; Manson, J. E.; Hunter, D. J.; Barbieri, R. L.; Colditz, G. A., and Hankinson, S. E. Journal of Clinical Oncology. 18(21):3668-3676, 2000 Nov 1.

Diet and breast carcinoma in multiethnic populations.
Wu, A. H. (Reprint available from: Wu AH Univ So Calif, Kenneth Norris Jr Comprehens Canc Ctr, Dept Prevent Med 1441 Eastlake Ave,MS 44,POB 33800 Los Angeles, CA 90033 USA. Cancer. 88(5 Suppl S):1239-1244, 2000 Mar 1. No abstract

2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine, a carcinogen in high temperature - cooked meat, and breast cancer risk.
Sinha, R.; Gustafson, D. R.; Kulldorff, M.; Wen, W. Q.; Cerhan, J. R., and Zheng, W. (Reprint available from: Sinha R NIH 6120 Execut Blvd,Rm 7028 Bethesda, MD 20892 USA).. Journal of the National Cancer Institute. 92(16):1352-1354, 2000 Aug 16. No abstract

Dietary folate consumption and breast cancer risk.
Rohan, T. E.; Jain, M. G.; Howe, G. R., and Miller, A. B (Reprint available from: Rohan TE Univ Toronto, Dept Publ Hlth Sci 3rd Floor, 12 Queens Pk Crescent Wing Toronto ON M5S 1A8 Canada).. Journal of the National Cancer Institute. 92(3):266-269, 2000 Feb 2. No abstract

Top of Page

Genetics, hereditary breast cancer

Genetic cancer risk assessment - Putting it all together
Weitzel, J. N. (Reprint available from: Weitzel JN City Hope Comprehens Canc Ctr, Dept Clin Canc Genet 1500 E Duarte Rd Duarte, CA 91010 USA).. Cancer. 86(11 Suppl S):2483-2492, 1999 Dec 1.

Contralateral breast cancer risk is influenced by the age at onset in BRCA1-associated breast cancer
Verhoog, L. C.; Brekelmans, C. T. M.; Seynaeve, C.; Meijers-Heijboer, E. J., and Klijn, J. G. M. (Reprint available from: Klijn JGM Univ Rotterdam Hosp, Dr Daniel Den Hoed Canc Ctr, Dept Med Oncol, Family Canc Clin Groene Hilledijk 301 NL-3075 EA Rotterdam Netherlands). British Journal of Cancer. 83(3):384-386, 2000 Aug.

Integration of family history and medical management of patients with hereditary cancers.
Tinley, S. T. and Lynch, H. T. (Reprint available from: Tinley ST Creighton Univ, Sch Med, Dept Prevent Med 2500 Calif Plaza Omaha, NE 68178 USA). Cancer. 86(11 Suppl S):2525-2532, 1999 Dec 1.

Genetic susceptibility for specific cancers - Medical liability of the clinician
Severin, M. J. (Reprint available from: Severin MJ Creighton Univ, Sch Med, Dept Prevent Med, William M Scholl Jurisprudence Div 2500 Calif Plaza Omaha, NE 68178 USA).. Cancer. 86(11 Suppl S):2564-2569, 1999 Dec 1.

Life expectancy gains from cancer prevention strategies for women with breast cancer and BRCA1 or BRCA2 mutations
Schrag, D.; Kuntz, K. M.; Garber, J. E., and Weeks, J. C.. Jama: Journal of the American Medical Association. 283(5):617-624, 2000 Feb 2.

Prophylactic oophorectomy in BRCA1 and BRCA2 mutation carriers
Rebbeck, T. R.. Journal of Clinical Oncology. 18(21 Suppl S):100S-103S, 2000 Nov 1.

Prevalence and penetrance of BRCA1 and BRCA2 mutations in a population-based series of breast cancer cases
Ponder, B. A. J.; Day, N. E.; Easton, D. F.; Pharoah, P. D. P.; Lipscombe, J. M.; Redman, K.; Antoniou, A.; Basham, V.; Gregory, J.; Gayther, S., and Dunning, A. (Reprint available from: Pharoah PDP Univ Cambridge, Strangeways Res Labs, CRC, Human Canc Genet Res Grp,Dept Oncol Worts Causeway Cambridge CB1 8RN England).. British Journal of Cancer. 83(10):1301-1308, 2000 Nov.

Presymptomatic DNA testing and prophylactic surgery in families with a BRCA1 or BRCA2 mutation.
Meijers-Heijboer, E. J.; Verhoog, L. C.; Brekelmans, C. T. M.; Seynaeve, C.; Tilanus-Linthorst, M. M. A.; Wagner, A.; Dukel, L.; Devilee, P.; van den OuwelandA. M. W. ; van Geel, A. N., and Klijn, J. G. M. Lancet. 355(9220):2015-2020, 2000 Jun 10.

What would you do? Specialists' perspectives on cancer genetic testing, prophylactic surgery, and insurance discrimination.
Matloff, E. T.; Shappell, H.; Brierley, K.; Bernhardt, B. A.; McKinnon, W., and Peshkin, B. N. Journal of Clinical Oncology. 18(12):2484-2492, 2000 Jun.

Frequency of BRCA1/BRCA2 mutations in a population-based sample of young breast carcinoma cases.
Thompson, J. D., and Ostrander, E. A.. Cancer. 88(6):1393-1402, 2000 Mar 15.

Clinical impact of molecular genetic diagnosis, genetic counseling, and management of hereditary cancer - Part I: Studies of cancer in families
Lynch, H. T.; Watson, P.; Shaw, T. G.; Lynch, J. F.; Harty, A. E.; Franklin, B. A.; Kapler, C. R.; Tinley, S. T., and Liu, B. (Reprint available from: Lynch HT Creighton Univ, Sch Med, Dept Prevent Med 2500 Calif Plaza Omaha, NE 68178 USA).. Cancer. 86(11 Suppl S):2449-2456, 1999 Dec 1.

Occult ovarian tumors in women with BRCA1 or BRCA2 mutations undergoing prophylactic oophorectomy
Lu, K. H.; Garber, J. E.; Cramer, D. W.; Welch, W. R.; Niloff, J.; Schrag, D.; Berkowitz, R. S., and Muto, M. G.. Journal of Clinical Oncology. 18(14):2728-2732, 2000 Jul.

Breast cancer genetics and managed care - The Kaiser permanente experience.
Kutner, S. E. (Reprint available from: Kutner SE Kaiser Permanente Santa Teresa Med Ctr, Dept Surg 250 Hosp Pkwy San Jose, CA 95119 USA). Cancer. 86(11 Suppl S):2570-2574, 1999 Dec 1.

Reproductive factors in hereditary breast cancer.
Jernstrom, H. C. B.; Johannsson, O. T.; Loman, N.; Borg, A., and Olsson, H Breast Cancer Research & Treatment. 58(3):295-301, 1999 Dec.

Chemoprevention options for BRCA1 and BRCA2 mutation carriers.
Eeles, R. A. and Powles, T. J. Journal of Clinical Oncology. 18(21 Suppl S):93S-99S, 2000 Nov 1.

Randomized trial of a specialist genetic assessment service for familial breast cancer
Brain, K.; Gray, J.; Norman, P.; France, E.; Anglim, C.; Barton, G.; Parsons, E.; Clarke, A.; Sweetland, H.; Tischkowitz, M.; Myring, J.; Stansfield, K.; Webster, D.; Gower-Thomas, K.; Daoud, R.; Gateley, C.; Monypenny, I.; Singhal, H.; Branston, L.; Sampson, J.; Roberts, E.; Newcombe, R.; Cohen, D.; Rogers, C.; Mansel, R. and others (Reprint available from: Brain K Univ Wales Coll Med, Inst Med Genet, Dept Med Stat Heath Pk Cardiff CF4 4XN S Glam Wales).. Journal of the National Cancer Institute. 92(16):1345-1351, 2000 Aug 16.

Absence of premalignant histologic, molecular, or cell biologic alterations in prophylactic oophorectomy specimens from BRCA1 heterozygotes
Barakat, R. R.; Federici, M. G.; Saigo, P. E.; Robson, M. E.; Offit, K., and Boyd, J.. Cancer. 89(2):383-390, 2000 Jul 15.

Prognostic significance of germline BRCA2 mutations in hereditary breast cancer patients.
Verhoog, L. C.; Berns EMJJ; Brekelmans, C. T. M.; Seynaeve, C.; Meijers-Heijboer, E. J., and Klijn, J. G. M. Journal of Clinical Oncology. 18(21 Suppl S):119S-124S, 2000 Nov 1.

Are BRCA1- and BRCA2-associated breast cancers different? Prognosis of BRCA1-associated breast cancer.
Robson, M. Journal of Clinical Oncology. 18(21 Suppl S):113S-118S, 2000 Nov 1.

Breast cancer risk in male twins: joint analyses of four twin cohorts in Denmark, Finland, Sweden and the United States
Whiteman, D. C.; Murphy, M. F. G.; Verkasalo, P. K.; Page, W. F.; Floderus, B.; Skytthe, A., and Holm, N. V. (Reprint available from: Whiteman DC Univ Oxford, Imperial Canc Res Fund, Gen Practice Res Grp Oxford England).. British Journal of Cancer. 83(9):1231-1233, 2000 Nov. In process

Population-based study of BRCA1 and BRCA2 mutations in 1035 unselected Finnish breast cancer patients.
Syrjakoski, K.; Vahteristo, P.; Eerola, H.; Tamminen, A.; Kivinummi, K.; Sarantaus, L.; Holli, K.; Blomqvist, C.; Kallioniemi, O. P.; Kainu, T., and Nevanlinna, H. (Reprint available from: Nevanlinna H Univ Helsinki, Cent Hosp, Dept Obstet & Gynecol POB 140,Haartmaninkatu 2 FIN-00029 Helsinki Finland). Journal of the National Cancer Institute. 92(18):1529-1531, 2000 Sep 20. No abstract

Participation in the cooperative family registry for breast cancer studies: Issues of informed consent.
Daly, M. B.; Offit, K.; Li, F.; Glendon, G.; Yaker, A.; West, D.; Koenig, B.; McCredie, M.; Venne, V.; Nayfield, S., and Seminara, D. (Reprint available from: Daly MB Fox Chase Canc Ctr 510 Township Line Rd Cheltenham, PA 19012 USA). Journal of the National Cancer Institute. 92(6):452-456, 2000 Mar 15. No abstract

The genetic testing process: How much counseling is needed?
Cummings, S. Journal of Clinical Oncology. 18(21 Suppl S):60S-64S, 2000 Nov 1. No abstract

Top of Page

Hormone replacement and breast cancer risk

Mammographic density changes in perimenopausal and postmenopausal women: is effect of hormone replacement therapy predictable?
Sterns, E. E. and Zee, B. Breast Cancer Research & Treatment. 59(2):125-132, 2000 Jan.

Menopausal estrogen and estrogen-progestin replacement therapy and breast cancer risk.
Schairer, C.; Lubin, J.; Troisi, R.; Sturgeon, S.; Brinton, L., and Hoover, R.. Jama: Journal of the American Medical Association. 283(4):485-491, 2000 Jan 26.

Effect of hormone replacement therapy on breast cancer risk: Estrogen versus estrogen plus progestin.
Ross, R. K.; Paganini-Hill, A.; Wan, P. C., and Pike, M. C. (Reprint available from: Ross RK Univ So Calif, Kenneth Norris Jr Comprehens Canc Ctr 1441 Eastlake Ave,Rm 8302B Los Angeles, CA 90089 USA).. Journal of the National Cancer Institute. 92(4):328-332, 2000 Feb 16.

Hormone replacement therapy in relation to risk of lobular and ductal breast carcinoma in middle-aged women
Li, C. I.; Weiss, N. S.; Stanford, J. L., and Daling, J. R.. Cancer. 88(11):2570-2577, 2000 Jun 1.

Hormone replacement therapy and breast cancer [Review].
Jacobs, H. S. Endocrine-Related Cancer. 7(1):53-61, 2000 Mar.

Biopsy confirmed benign breast disease, postmenopausal use of exogenous female hormones, and breast carcinoma risk.
Byrne, C.; Connolly, J. L.; Colditz, G. A., and Schnitt, S. J.. Cancer. 89(10):2046-2052, 2000 Nov 15.

Postmenopausal estrogens - Opposed, unopposed, or none of the above
Willett, W. C.; Colditz, G., and Stampfer, M. (Reprint available from: Willett WC Harvard Univ, Sch Publ Hlth, Dept Nutr 667 Huntington Ave Boston, MA 02115 USA).. Jama: Journal of the American Medical Association. 283(4):534-535, 2000 Jan 26. No abstract

Re: Effect of hormone replacement therapy on breast cancer risk: Estrogen versus estrogen plus progestin
Archer, D. F.; Bush, T., and Nachtigall, L. E. (Reprint available from: Nachtigall LE NYU, Sch Med, Dept Obstet & Gynecol 251 E 33rd St New York, NY 10016 USA).. Journal of the National Cancer Institute. 92(23):1950-1951, 2000 Dec 6. No abstract

Lifestyle and breast cancer prevention

Breast cancer among former college athletes compared to non-athletes: a 15-year follow-up.
Wyshak, G. and Frisch, R. E. (Reprint available from: Wyshak G Harvard Univ, Sch Publ Hlth, Dept Populat & Int Hlth 665 Huntington Ave Boston, MA 02115 USA) British Journal of Cancer. 82(3):726-730, 2000 Feb.

Passive smoking exposure and female breast cancer mortality. Journal of the National Cancer Institute.
Wartenberg, D.; Calle, E. E.; Thun, M. J.; Heath, C. W.; Lally, C., and Woodruff, T. (Reprint available from: Wartenberg D Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Environm & Occupat Hlth Sci Inst 170 Frelinghuysen Rd Piscataway, NJ 08854 USA). 92(20):1666-1673, 2000 Oct 18.

Physical activity and breast cancer risk in women aged 20-54 years.
Verloop, J.; Rookus, M. A.; van der Kooy, K., and van Leeuwen, F. E. (Reprint available from: van Leeuwen FE Netherlands Canc Inst, Dept Epidemiol Plesmanlaan 121 NL-1066 CX Amsterdam Netherlands). Journal of the National Cancer Institute. 92(2):128-135, 2000 Jan 19.

Breast cancer incidence in relation to smoking cessation.
Manjer, J.; Berglund, G.; Bondesson, L.; Garne, J. P.; Janzon, L., and Malina, J. (Reprint available from: Manjer J Univ Lund, Malmo Univ Hosp, Dept Community Med, Epidemiol Unit S-20502 Malmo Sweden).. Breast Cancer Research & Treatment. 61(2):121-129, 2000 May.

Alcohol and breast cancer risk: the alcoholism paradox.
Kuper, H.; Ye, W.; Weiderpass, E.; Ekbom, A.; Trichopoulos, D.; Nyren, O., and Adami, H. O. (Reprint available from: Adami HO Harvard Univ, Dept Epidemiol Boston, MA 02115 USA). British Journal of Cancer. 83(7):949-951, 2000 Oct.

Top of Page

Prophylactic mastectomies

Women's regrets after bilateral prophylactic mastectomy.
Payne, D. K.; Biggs, C.; Tran, K. N.; Borgen, P. I., and Massie, M. J. Annals of Surgical Oncology. 7(2):150-154, 2000 Mar.

Intention to undergo prophylactic bilateral mastectomy in women at increased risk of developing hereditary breast cancer.
Meiser, B.; Butow, P.; Friedlander, M.; Schnieden, V.; Gattas, M.; Kirk, J.; Suthers, G.; Haan, E., and Tucker, K.. Journal of Clinical Oncology. 18(11):2250-2257, 2000 Jun.

Prophylactic surgery in women with a hereditary predisposition to breast and ovarian cancer [Review].
Eisen, A.; Rebbeck, T. R.; Wood, W. C., and Weber, B. L. Journal of Clinical Oncology. 18(9):1980-1995, 2000 May.

Long-term satisfaction and psychological and socia function following bilateral prophylactic mastectomy.
Frost, M. H.; Schaid, D. J.; Sellers, T. A.; Slezak, J. M.; Arnold, P. G.; Woods, J. E.; Petty, P. M.; Johnson, J. L.; Sitta, D. L.; McDonnell, S. K.; Rummans, T. A.; Jenkins, R. B.; Sloan, J. A., and Hartmann, L. C.. Jama: Journal of the American Medical Association. 284(3):319-324, 2000 Jul 19.

Drive-through mastectomy and breast reconstruction.
Kroll, S. S. (Reprint available from: Kroll SS Univ Texas, MD Anderson Canc Ctr, Dept Plast Surg Box 62,1515 Holcombe Blvd Houston, TX 77030 USA). Annals of Surgical Oncology. 7(6):399-401, 2000 Jul. No abstract

Top of Page

Pathogenesis of breast cancer

Pathogenesis of Paget's disease: Epidermal heregulin-alpha, motility factor, and the HER receptor family.
Schelfhout, V. R. J.; Coene, E. D.; Delaey, B.; Thys, S.; Page, D. L., and De Potter, C. R. (Reprint available from: De Potter CR State Univ Ghent Hosp, N Goormaghtigh Inst Pathol De Pintelaan 185 B-9000 Ghent Belgium). Journal of the National Cancer Institute. 92(8):622-628, 2000 Apr 19.

Balance of cell proliferation and apoptosis in breast carcinogenesis.
Mommers, E. C. M.; van Diest, P. J.; Leonhart, A. M.; Meijer CJLM, and Baak, J. P. A. Breast Cancer Research & Treatment. 58(2):163-169, 1999 Nov.

alpha-fetoprotein levels in maternal serum during pregnancy and maternal breast cancer incidence.
Melbye, M.; Wohlfahrt, J.; Lei, U.; Norgaard-Pedersen, B.; Mouridsen, H. T.; Lambe, M., and Michels, K. B. (Reprint available from: Melbye M Statens Serum Inst, Dept Epidemiol Res 5 Artillerivej DK-2300 Copenhagen S Denmark). Journal of the National Cancer Institute. 92(12):1001-1005, 2000 Jun 21.

Polyamine profiles in tumor, normal tissue of the homologous breast, blood, and urine of breast cancer sufferers.
Leveque, J.; Foucher, F.; Bansard, J. Y.; Havouis, R.; Grall, J. Y., and Moulinoux, J. P. (Reprint available from: Leveque J Ctr Hosp & Univ Rennes, Serv Gynecol B, Hop Sud 16 Bd Bulgarie,BP 56129 F-35056 Rennes 2 France).. Breast Cancer Research & Treatment. 60(2):99-105, 2000 Mar.

Tissue architecture and breast cancer: the role of extracellular matrix and steroid hormones [Review].
Hansen, R. K. and Bissell, M. J. Endocrine-Related Cancer. 7(2):95-113, 2000 Jun.

Top of Page